Cervical Cancer: Our Clinical Trials

In addition to providing excellent care for women with cervical cancer, we lead a number of clinical trials to improve on current standards for treatment and enhance survival and quality of life. We lead clinical trials through our research programs as well as through the efforts of the Gynecologic Oncology Group, a multi-institutional clinical research effort supported by the National Cancer Institute.

Clinical trials are research studies that evaluate the safety and effectiveness of new ways to diagnose and treat cervical cancer. These studies can also help doctors compare the effectiveness of prevention strategies or other aspects of your care.

Our clinical research team is highly experienced in selecting women who are mostly likely to benefit from a particular investigational therapy and in guiding patients through the process of enrolling in the most appropriate clinical trial. If you are eligible to participate in a clinical trial, you may have access to new therapies that are not yet widely available.

The following cervical cancer clinical trials at Memorial Sloan Kettering are currently enrolling patients. To learn more about a study, choose from the list below.

Showing 9 trials
Title Investigatorsort icon
A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Cancer Following Radical Hysterectomy
[Protocol 10-173]
Leitao, Mario, MD
A Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Patients with Intermediate-Risk, Stage I/IIA Cervical Cancer Treated with Surgery
[Protocol 11-007]
Leitao, Mario, MD
A Phase I/II Study of Paclitaxel, Cisplatin, and ABT-888 (Velaparib) to Treat Advanced, Persistent, or Recurrent Cervical Cancer
[Protocol 11-131]
Leitao, Mario, MD
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact in Newly Diagnosed Patients
[Protocol 12-190]
Leitao, Mario, MD
A Phase III Study Assessing Chemoradiation Alone and with Additional Chemotherapy in Women with Locally Advanced, Inoperable Cervical Cancer: The OUTBACK Trial
[Protocol 12-171]
Leitao, Mario, MD
Evaluation of Physical Function and Quality of Life Before and After Non-Radical Surgery for Stage I Cervical Cancer
Newly Diagnosed
[Protocol 13-210]
Leitao, Mario, MD
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander, MD
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
[Protocol 08-155]
Chi, Dennis, MD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret, MD, PhD